Efficacy of the potentized homeopathic drug, Carcinosin 200, fed alone and in combination with another drug, Chelidonium 200, in amelioration of p-dimethylaminoazobenzene-induced hepatocarcinogenesis in mice

Journal of Alternative and Complementary Medicine

Volumn 11, Issue 5, 2005, Pages 839-854

  Biswas, Surjyo Jyoti ^a   Pathak, Surajit ^a   Bhattacharjee, Nandini ^a   Das, Jayanta Kumar ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ACID PHOSPHATASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARCINOSIN 200; CHELIDONIUM 200; HOMEOPATHIC AGENT; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DRUG EFFECT; DRUG EFFICACY; HOMEOPATHY; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER TUMOR; MICROSCOPY; MITOSIS INDEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPERMATOZOON ABNORMALITY; TISSUE INJURY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CHELIDONIUM; CHROMOSOME ABERRATIONS; HOMEOPATHY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; P-DIMETHYLAMINOAZOBENZENE; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 28444450816     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2005.11.839     Document Type: Article

References (35)

1. Daoust R, Molnar F. Cellular populations and mitotic activity in rat liver parenchyma during azo dye carcinogenesis. Cancer Res 1964;24:1898-1909.
2. Samuels AR, Bhargava M, Levine WG. Uptake of hepatobiliary fate of two hepatocarcinogens, N,N-dimethyl-4-aminoazobenzene and 3′-methyl-N,N- dimethyl-4-aminoazobenzene, in rat. Cancer Res 1983;43:4816-4821.
3. Kitagawa T, Sugano H. Enhancement of azodye hepatocarcinogenesis with dietary phenobarbital in rats. Gann 1977;68:255-256.
4. Biswas SJ, Khuda Bukhsh AR. Effect of homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice. BMC Complement Altern Med 2002;2:4.
5. Biswas SJ, Khuda Bukhsh AR. Evaluation of protective potentials of a potentized homeopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice. Indian J Exp Biol 2004;42:698-714.
6. Boericke W. Pocket Manual of Homeopathic Meteria Medica, Indian Edition. Calcutta, India: Sett Dey and Co., 1976.
7. Khuda Bukhsh AR. Towards understanding molecular mechanisms of action of homeopathic drugs: An overview. Mol Cell Biochem 2003;253:339-345.
8. Varma PN, Vaid I, eds. Encyclopaedia of Homoeopathic Pharmacopoeia. Vol I B. New Delhi, India: Jain Publishers, 2002:654-657.
9. Datta S, Mallick P, Khuda Bukhsh AR. Comparative efficacy of two microdoses of a potentized homeopathic drug, Cadmium Sulphoricum, in reducing cytogenetical effects produced by cadmium chloride in mice: A time-course study. BMC Complement Altern Med 2001;1:1-18.
10. Datta S, Mallick P, Khuda-Bukhsh AR. Efficacy of a potentized homeopathic drug (Arsenic Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: Comparative studies of pre-, post- and combined pre-and post-oral administration and comparative efficacy of two microdoses. Complement Ther Med 1999;7:62-75.
11. Datta S, Mallick P, Khuda-Bukhsh AR. Efficacy of a potentized homeopathic drug (Arsenic Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: II. Comparative efficacy of an antibiotic, actinomycin D alone and in combination with either of two microdoses. Comlement Ther Med 1999;7:156-163.
12. Biswas SJ, Pathak S, Khuda-Bukhsh AR. Assessment of genotoxic and cytotoxic potentials of an anti-epileptic drug, phenobarbital in mice. Mutat Res 2004;563:1-11.
13. Schmid W, Hollaender AE. eds. Chemical Mutagens: Principles and Methods of Detection. New York: Plenum Press, 1976:31-53.
14. Wyrobek AJ, Watchmaker G, Gordon L. Sperm morphology testing in mice. In: Kilbey BJ, Legator M, Nichols W, Ramel C, eds. Handbook of Mutagenicity Testing Protocols. New York: Elsevier Science, 1984:733-750.
15. Buege JA, Aust S. Microsomal lipid peroxidation. Methods Enzymol 1984;105:302-310.
16. Bergmeyer HU, Brent E. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis, vol 2. New York: Academic Press, 1974:735-760.
17. Walter K, Schutt C. Acid and alkaline phosphatase in serum (two-point method). In: Bergmeyer HU, eds. Methods in Enzymatic Analysis, vol 2. New York: Academic Press, 1974:856-860.
18. Kitagawa T, Pitot HC, Miller EC, Miller JA. Promotion by dietary phenobarbital of hepatocarcinogenesis by 2 methyl-N,N-dimethyl-4-aminoazobenzene in the rat. Cancer Res 1979;39:112-115.
19. Hathway DE. Mechanisms of chemical carcinogenesis. Oxford, UK: Butterworth, 1986:14-55.
20. Yamamoto R, Iishi H, Tatsuta M, et al. Inhibitory effect of sialoadenectomy on hepatocellular tumorigenesis in male mice induced by 3″-methyl-4-dimethylaminoazobenzene. Virchows Arch 1994;425:79-82.
21. Caballero F, Gerez E, Oliven L, et al. On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p- dimethylaminoazobenzene in CF1 mice. Int J Biochem Cell Biol 2001;33:681-690.
22. Ohnishi S, Murata M, Degawa M, Kawanishi S. Oxidative DNA damage induced by an N-hydroxy metabolite of carcinogenic 4-dimethylaminoazobenzene. Jpn J Cancer Res 2001;92:23-29.
23. Vavreckova C, Gawlik I, Muller K. Benzophenanthridine alkaloids of Chelidonium majus: II. Potent inhibitory action against the growth of human keratinocytes. Planta Med 1996;62:491-494.
24. Vavreckova C, Gawlik I, Muller K. Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non redox mechanism. Planta Med 1996;62:397-401.
25. Khuda-Bukhsh AR. Potentized homeopathic drugs act through regulation of gene expression: A hypothesis to explain their mechanism and pathways of action in vivo. Complement Ther Med 1997;5:43-46.
26. Ernst E, Pittler MH, Stevenson C, White AR. The Desk Top Guide to Complementary and Alternative Medicine. Edinburgh, Mosby, 2001.
27. Ernst E. The current position of complementary/alternative medicine in cancer. Eur J Cancer 2003;39:2273-2277.
28. Weigant FAC, Van Rijn J, van Wijk R. Enhancement of the stress response by minute amounts of cadmium in sensitized Reuber H35 hepatoma cells. Toxicology 1997;116:27-37.
29. Fisher P. Research in Homeopathy-A Bibliography Compiled and Annotated by Dr. P Fisher, 8th ed. London: Royal London Homeopathic Hospital, 1992.
30. Linde K, Jonas WB, Worke DMF, et al. Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol 1994;13:481-492.
31. Linde K, Clausius N, Remirez G, et al. Overviews and meta-analyses of controlled clinical trials of homeopathy. In: Ernst E, Hahn EG, eds. Homeopathy: A Critical Appraisal. London: Butterworth-Heinemann, Reed Educational and Professional Publishing, Ltd., 1998.
32. Shen J, Anderson R, Albert PS. Use of complementary and alternative therapies by women with advanced stage breast cancer. BMC Complement Altern Med 2002;2:8-15.
33. Wilkinson S, Cornelia LG, Smith JA. Attitudes and use of complementary medicine in men with prostrate cancer. J Urol 2002;168:2505-2509.
34. Chrystal K, Allan S, Forgeson G, Isaacs R. The use of complementary and alternative medicine by cancer patients in New Zealand and regional cancer treatment center. New Zealand Med J 2003;116:1-8.
35. Pathak Sen, Multani AS, Banerji P, Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int J Oncol 2003;23:975-982.